Indication
Used in the treatment of cardiovascular diseases.
Administration
tab: Should be taken on an empty stomach.
Contraindications
Current or history of bronchial asthma or bronchospasm; bradycardia, cardiogenic shock, hypotension, metabolic acidosis, after prolonged fasting, severe peripheral arterial circulatory disturbances, 2nd- or 3rd-degree heart block, sick sinus syndrome, Prinzmetal's angina, uncontrolled heart failure, phaeochromocytoma that has not been treated with α-receptor blocker. Additional contraindications for Hemangeol: Heart rate <80 bpm, blood pressure <50/30 mmHg; premature infants with corrected age <5 weeks and infants weighing <2 kg.
Special Precautions
Patient with 1st-degree heart block, compensated heart failure, diabetes mellitus, myasthenia gravis, history of anaphylactic reaction to allergens, less severe peripheral circulatory disturbances, Wolff-Parkinson-White Syndrome. Patient undergoing surgery. Avoid abrupt withdrawal (particularly in patients with ischaemic heart disease); chronic therapy must not be routinely withdrawn before major surgery. May mask the signs and symptoms of hypoglycaemia and hyperthyroidism (particularly tachycardia). Renal and hepatic impairment. Neonates, children, and elderly. Pregnancy and lactation.
Storage
Store between 15-30°C. Protect from light, moisture, or excessive heat.
MedsGo Class
Antimigraine Preparations / Beta-Blockers